Inogen gains after FDA approves airway clearing device

Inogen

30/12/2024 14:08

** Shares of medical device maker Inogen  INGN.O  rise 10.6%
to $9.49 premarket
    ** Co says its device for clearing mucus from lungs has
received FDA 510(k) approval
    ** FDA 510(k) approval is a process where a medical device
is shown to be safe and similar to an existing device before it
can be sold
    ** The device, SIMEOX 200 Airway Clearance Device, helps
improve bronchial drainage in patients with chronic respiratory
diseases - INGN
    ** The device is intended for patients who can cough on
their own - INGN
    ** Co plans a limited launch of the device at targeted sites
in 2025
    ** As of last close, stock has risen 56.3% YTD

 (Reporting by Kamal Choudhury in Bengaluru)
 ((Kamal.Choudhury@thomsonreuters.com;))